Home > Insider Trading > Filing (0001104659-20-131769)

Filing Details

Accession Number:: 0001104659-20-131769
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-12-03 06:06:40
Reporting Period:: 2020-12-01

Accepted Time:: 2020-12-03 06:06:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1824893	Consonance-Hfw Acquisition Corp.	CHFW	Blank Checks (6770)	981556622

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1828234	Harold Kevin Livingston	C/O Consonance-Hfw Acquisition Corp. 1 Palmer Square, Suite 305 Princeton NJ 08540	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Acquisiton	2020-12-01	24,000	$0.00	434,000	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Ordinary Shares	Warrant	Acquisiton	2020-12-01	8,000	$0.00	8,000	$11.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
144,667			No	4	P	Indirect

Footnotes

Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences (the "Sponsor") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share.
The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.
The warrants will expire five years after the completion of the Issuer's initial business combination.
Includes 8,000 warrants underlying the units referred to in footnote 1.